JP2017523189A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523189A5
JP2017523189A5 JP2017505081A JP2017505081A JP2017523189A5 JP 2017523189 A5 JP2017523189 A5 JP 2017523189A5 JP 2017505081 A JP2017505081 A JP 2017505081A JP 2017505081 A JP2017505081 A JP 2017505081A JP 2017523189 A5 JP2017523189 A5 JP 2017523189A5
Authority
JP
Japan
Prior art keywords
composition
stage
patent document
dry powder
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017505081A
Other languages
English (en)
Japanese (ja)
Other versions
JP6850524B2 (ja
JP2017523189A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/043128 external-priority patent/WO2016019253A1/en
Publication of JP2017523189A publication Critical patent/JP2017523189A/ja
Publication of JP2017523189A5 publication Critical patent/JP2017523189A5/ja
Application granted granted Critical
Publication of JP6850524B2 publication Critical patent/JP6850524B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017505081A 2014-07-31 2015-07-31 吸入用の乾燥粉末製剤 Active JP6850524B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462031811P 2014-07-31 2014-07-31
US62/031,811 2014-07-31
PCT/US2015/043128 WO2016019253A1 (en) 2014-07-31 2015-07-31 Dry powder formulations for inhalation

Publications (3)

Publication Number Publication Date
JP2017523189A JP2017523189A (ja) 2017-08-17
JP2017523189A5 true JP2017523189A5 (cg-RX-API-DMAC7.html) 2018-09-13
JP6850524B2 JP6850524B2 (ja) 2021-03-31

Family

ID=55218356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505081A Active JP6850524B2 (ja) 2014-07-31 2015-07-31 吸入用の乾燥粉末製剤

Country Status (10)

Country Link
EP (2) EP4218734A1 (cg-RX-API-DMAC7.html)
JP (1) JP6850524B2 (cg-RX-API-DMAC7.html)
KR (2) KR102666667B1 (cg-RX-API-DMAC7.html)
CN (2) CN116687887A (cg-RX-API-DMAC7.html)
AU (2) AU2015296142A1 (cg-RX-API-DMAC7.html)
CA (1) CA2991760C (cg-RX-API-DMAC7.html)
DK (1) DK3179986T3 (cg-RX-API-DMAC7.html)
ES (1) ES2942297T3 (cg-RX-API-DMAC7.html)
PL (1) PL3179986T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016019253A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016176552A1 (en) * 2015-04-30 2016-11-03 Otitopic Inc. Dry power formulations for inhalation
EP3463378A4 (en) 2016-06-03 2020-01-08 Otitopic Inc. DRY POWDER FORMULAS FOR INHALATION
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
CA3076353A1 (en) * 2017-09-22 2019-03-28 Otitopic Inc. Dry powder compositions with magnesium stearate
EP4311566A1 (en) 2022-07-28 2024-01-31 Vectura Inc. An inhaler comprising a retention element
KR20260081332A (ko) 2024-11-25 2026-06-04 충북대학교 산학협력단 머신 러닝 기반 건조분말 흡입제제의 흡입 효율 예측 시스템 및 방법

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
AU706195B2 (en) 1995-04-14 1999-06-10 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
MX9707862A (es) 1995-04-14 1997-11-29 Glaxo Wellcome Inc Inhalador de dosis medida para el propionato de fluticasona.
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998055104A1 (fr) * 1997-06-06 1998-12-10 Shionogi & Co., Ltd. Perfectionnement d'un systeme d'administration de medicament
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
ATE248583T1 (de) 1997-09-29 2003-09-15 Nektar Therapeutics In dosierinhalatoren verwendbare, stabilisierte zubereitungen
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
WO2000000215A1 (en) 1998-06-29 2000-01-06 Inhale Therapeutic Systems, Inc. Particulate delivery systems and methods of use
GB9814172D0 (en) 1998-06-30 1998-08-26 Andaris Ltd Formulation for inhalation
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2292598T3 (es) * 2000-06-27 2008-03-16 Vectura Limited Metodo para producir particulas para usar en una composicion farmaceutica.
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
US20080044481A1 (en) 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
AU2006230242B2 (en) 2005-03-28 2013-05-30 Pericor Therapeutics, Inc. Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
EP1898911A1 (en) * 2005-06-13 2008-03-19 Elan Pharma International Limited Nanoparticulate clopidogrel and aspirin combination formulations
GB0621957D0 (en) * 2006-11-03 2006-12-13 Vectura Group Plc Inhaler devices and bespoke pharmaceutical compositions
WO2009026434A1 (en) 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
EP2252275B1 (en) 2008-02-13 2017-11-29 Board of Regents, The University of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery
CA2759109A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd A solid dosage form of ciprofloxacin having small particle size and improved powder handling characteristics
GB201102237D0 (en) * 2011-02-09 2011-03-23 Kuecept Ltd Particle formulation
US9216527B2 (en) 2012-02-09 2015-12-22 G & W Electric Company Solid-dielectric switch including a molded viewing window
CN107875127A (zh) 2012-02-28 2018-04-06 艾塞尤提卡控股公司 可吸入药物组合物
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
CN105473133A (zh) * 2013-04-30 2016-04-06 欧缇托匹克公司 干粉制剂及使用方法
EP3107548B8 (en) 2014-02-20 2022-07-20 Otitopic Inc. Dry powder formulations for inhalation

Similar Documents

Publication Publication Date Title
JP7623854B2 (ja) 乾燥粉末配合および使用方法
JP2016518388A5 (cg-RX-API-DMAC7.html)
ES2664175T3 (es) Formulación de polvo seco que comprende un inhibidor de fosfodiesterasa
US10391078B2 (en) Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP6129081B2 (ja) 頻拍を治療するためのグリコピロラートの使用
JP2022137070A5 (cg-RX-API-DMAC7.html)
CN105377240A (zh) 固体药物剂型
JP6850524B2 (ja) 吸入用の乾燥粉末製剤
JP2007530620A (ja) メロキシカムを含む組成物
JP5542309B2 (ja) 経口医薬組成物
JP6415536B2 (ja) ブデソニドおよびフォルモテロールを含む医薬組成物
JP2023550407A (ja) 肺高血圧向けの吸入式イマチニブ
CN110251473A (zh) 羟哌吡酮口服缓释制剂
Dhoble et al. Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension
WO2013026270A1 (zh) 右布洛芬左西替利嗪缓释双层片在治疗气道炎症中的用途
JP5175710B2 (ja) 急性および慢性気管支炎治療における吸入による非ステロイド系抗炎症剤の使用
ES2647223T3 (es) Vapendavir para el alivio de los síntomas del asma en un sujeto que tiene una infección por el VRH
JP5433295B2 (ja) キサンタンガム被覆水溶性糖類及び圧縮成形製剤
JP2009007295A (ja) イブプロフェンの昇華が抑制された固形製剤
KR102449403B1 (ko) 부데소니드 및 포르모테롤을 함유하는 약학 조성물
JP6159128B2 (ja) 抗ロタウイルス剤
JP2013151565A (ja) イブプロフェンの昇華が抑制された固形製剤
JP4318899B2 (ja) 抗感冒剤
JPWO2005063253A1 (ja) アレルギー症状治療用医薬組成物
CN103006657B (zh) 一种含有愈创木酚的复方化学药物